farshid dayyani, md | ctdna and mrd testing with the expanded access program
Published 4 years ago • 76 plays • Length 5:34
Download video MP4
Download video MP3
Similar videos
-
0:53
farshid dayyani, md | importance of ctdna and mrd testing
-
9:00
adham jurdi, md | ctdna and mrd testing with the expanded access program
-
8:45
jun gong, md | ctdna and mrd testing with the expanded access program
-
2:01
farshid dayyani, md | what is signatera?
-
1:06
farshid dayyani, md | expanded access programs in cancer and their importance during covid-19
-
58:52
ctdna and mrd | 2023 best of gi cancer conference
-
3:25
understand ctdna testing
-
21:48
13 interior design trends that should die in 2022! *cancel these impractical trends asap*
-
2:58
urmeel patel, md | signatera, expanded access programs, and surveillance
-
1:05:21
ctdna and mrd testing | colorectal cancer care tools for surveillance
-
1:10
farshid dayyani, md | importance of surveillance to patients during this time of covid-19
-
46:53
ctdna and mrd: who, when, and then what? | 2022 evolution conference
-
1:53
farshid dayyani, md | practical guidance and clinical operations during covid19
-
1:30
gregory botta, md, phd | what is signatera?
-
49:45
a ctdna assay for remote monitoring and risk stratification
-
1:43
axel grothey, md | what is signatera?
-
0:21
circulating tumor cells
-
2:33
arturo loaiza-bonilla, md | what is signatera?
-
2:42
what is circulating tumor dna (ctdna)?
-
2:33
linking the diagnosis-to-treatment interval with ctdna
-
1:15
hybrid ftrd cecal of a adenoma
Clip.africa.com - Privacy-policy